Johnson & Johnson JNJ
NYSE · United States · Health Technology
$264.74-2.83 (-1.06%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Zacks highlights Johnson & Johnson, Coca-Cola and AbbVie for years of dividend increases and says their shares have outperformed the S&P 500 in 2026.
The portfolio agent holds Caterpillar while keeping more than half its funds in cash, and the stock has several growth drivers.
Johnson & Johnson shares climbed despite slower revenue growth, as investors weigh new-drug momentum against Stelara losses and softer MedTech sales.